| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Email: |
3003867561@qq.com |
| Products Intro: |
Product Name:Nexopamil racemate
CAS:116759-35-4
Purity:98% Package:5mg；10mg；20mg；50mg；100mg；200mg
|
Nexopamil (racemate) manufacturers
- Nexopamil racemate
-
- $1800.00 / 5mg
-
2025-09-17
- CAS:116759-35-4
- Min. Order:
- Purity: 98.61%
- Supply Ability: 10g
- Nexopamil racemate
-
- $1800.00 / 5mg
-
2025-08-22
- CAS:116759-35-4
- Min. Order:
- Purity: 98.61%
- Supply Ability: 10g
|
| | Nexopamil (racemate) Basic information |
| Product Name: | Nexopamil (racemate) | | Synonyms: | Nexopamil (racemate);5-[N-methyl-N-(n-hexyl)]-amino-2-(3,4,5-trimethoxyphenyl)-2-isopropylvaleronitrile;Benzeneacetonitrile, α-[3-(hexylmethylamino)propyl]-3,4,5-trimethoxy-α-(1-methylethyl)- | | CAS: | 116759-35-4 | | MF: | C24H40N2O3 | | MW: | 404.6 | | EINECS: | | | Product Categories: | | | Mol File: | 116759-35-4.mol |  |
| | Nexopamil (racemate) Chemical Properties |
| Boiling point | 514.7±50.0 °C(Predicted) | | density | 0.985±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | pka | 9?+-.0.50(Predicted) |
| | Nexopamil (racemate) Usage And Synthesis |
| Uses | Nexopamil racemate is the racemate of Nexopamil. Nexopamil is a combined Ca2+/5-HT2 antagonist on thrombus formation in vivo and on platelet aggregation in vitro. | | in vivo | Nexopamil (0.05 mg/kg) completely abolishes cyclic flow reductions (CFRs) during the first 30 min after application without significantly altering hemodynamics[1]. | | IC 50 | 5-HT2 Receptor | | References | [1] Kirchengast M, et al. Inhibition by the combined Ca2+ and 5-HT2 receptor antagonist nexopamil (LU 49938) of intracoronary thrombus formation in a canine model of arterial stenosis and intimal damage. J Cardiovasc Pharmacol. 1993 Nov;22(5):687-94. DOI:10.1097/00005344-199311000-00003 |
| | Nexopamil (racemate) Preparation Products And Raw materials |
|